What does APOTHEEK VERSCHAEVE-BARTELEN do?

APOTHEEK VERSCHAEVE-BARTELEN is a pharmacy in Beveren-Kruibeke-Zwijndrecht. Private Limited, started on 31 January 1994, 1 establishment.

What is the address of APOTHEEK VERSCHAEVE-BARTELEN?

The registered office of APOTHEEK VERSCHAEVE-BARTELEN is located at Dorpstraat 141, 2070 Beveren-Kruibeke-Zwijndrecht.

Is APOTHEEK VERSCHAEVE-BARTELEN still active?

Yes. According to the CBE (2 November 2026) APOTHEEK VERSCHAEVE-BARTELEN is active, legal situation “Normale toestand”, started on 31 January 1994.

Is APOTHEEK VERSCHAEVE-BARTELEN registered on Peppol?

Yes, APOTHEEK VERSCHAEVE-BARTELEN is registered on the Peppol network with ID 0208:0451903303.

What is the enterprise number of APOTHEEK VERSCHAEVE-BARTELEN?

The enterprise number of APOTHEEK VERSCHAEVE-BARTELEN is BE0451903303.

When was APOTHEEK VERSCHAEVE-BARTELEN founded?

APOTHEEK VERSCHAEVE-BARTELEN was founded on 31 January 1994.

Who are the directors of APOTHEEK VERSCHAEVE-BARTELEN?

According to the 2025 annual accounts, the directors of APOTHEEK VERSCHAEVE-BARTELEN are: Pamixx.

Is APOTHEEK VERSCHAEVE-BARTELEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 January 1994; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK VERSCHAEVE-BARTELEN make in 2025?

APOTHEEK VERSCHAEVE-BARTELEN posted a profit after taxes of € 77,830 in financial year 2025.

What is the revenue of APOTHEEK VERSCHAEVE-BARTELEN?

As a small company, APOTHEEK VERSCHAEVE-BARTELEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 131,468.

APOTHEEK VERSCHAEVE-BARTELEN (Private Limited)

Dossier APOTHEEK VERSCHAEVE-BARTELEN, printed on 3 November 2026 from databakkes.be/en/0451903303/apotheek-verschaeve-bartelen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK VERSCHAEVE-BARTELEN from Beveren-Kruibeke-Zwijndrecht, company number BE0451903303, closed financial year 2025 with a result of € 77,830 after tax. For that financial year APOTHEEK VERSCHAEVE-BARTELEN recorded a gross margin of € 131,468 and equity of € 1,000. Compared with financial year 2024, the result moved from € 79,863 to € 77,830. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 3, 2025.

What it is worth Healthy

€ 1,000

▼ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 77,830

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 84,946

▼ 50% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 77,830 paid out

100 % of the profit went to the shareholders, mostly to Waelput Invest (100 % of the shares). That is where the money ends up.

People and assets in 2025

Vehicles and equipment

€ 6,357

▼ 62% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 56,531

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 580

▲ 197% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 137,172 Gross margin 2022: € 137,172 First fiscal year in the series	€ 143,998 Gross margin 2023: € 143,998 ▲ 5% vs 2022 (€ 137,172) Favourable step	€ 144,279 Gross margin 2024: € 144,279 Unchanged (€ 143,998) Favourable step	€ 131,468 Gross margin 2025: € 131,468 ▼ 9% vs 2024 (€ 144,279) Unfavourable step	▼ 9%
Profit after taxes	€ 77,607 Profit after taxes 2022: € 77,607 First fiscal year in the series	€ 80,612 Profit after taxes 2023: € 80,612 ▲ 4% vs 2022 (€ 77,607) Favourable step	€ 79,863 Profit after taxes 2024: € 79,863 ▼ 1% vs 2023 (€ 80,612) Unfavourable step	€ 77,830 Profit after taxes 2025: € 77,830 ▼ 3% vs 2024 (€ 79,863) Unfavourable step	▼ 3%
Equity	€ 102,035 Equity 2022: € 102,035 First fiscal year in the series	€ 22,647 Equity 2023: € 22,647 ▼ 78% vs 2022 (€ 102,035) Unfavourable step	€ 1,607 Equity 2024: € 1,607 ▼ 93% vs 2023 (€ 22,647) Unfavourable step	€ 1,000 Equity 2025: € 1,000 ▼ 38% vs 2024 (€ 1,607) Unfavourable step	▼ 38%
Total debts	€ 501,006 Total debts 2022: € 501,006 First fiscal year in the series	€ 474,543 Total debts 2023: € 474,543 ▼ 5% vs 2022 (€ 501,006) Favourable step	€ 531,825 Total debts 2024: € 531,825 ▲ 12% vs 2023 (€ 474,543) Unfavourable step	€ 404,689 Total debts 2025: € 404,689 ▼ 24% vs 2024 (€ 531,825) Favourable step	▼ 24%
Cash	€ 171,302 Cash 2022: € 171,302 First fiscal year in the series	€ 70,429 Cash 2023: € 70,429 ▼ 59% vs 2022 (€ 171,302) Unfavourable step	€ 169,751 Cash 2024: € 169,751 ▲ 141% vs 2023 (€ 70,429) Favourable step	€ 84,946 Cash 2025: € 84,946 ▼ 50% vs 2024 (€ 169,751) Unfavourable step	▼ 50%
Retained profit	€ 83,485 Retained profit 2022: € 83,485 First fiscal year in the series	€ 4,097 Retained profit 2023: € 4,097 ▼ 95% vs 2022 (€ 83,485) Unfavourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 4,097) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 158,000 Dividend 2022: € 158,000 First fiscal year in the series	€ 160,000 Dividend 2023: € 160,000 ▲ 1% vs 2022 (€ 158,000) Unchanged	€ 100,903 Dividend 2024: € 100,903 ▼ 37% vs 2023 (€ 160,000) Unchanged	€ 77,830 Dividend 2025: € 77,830 ▼ 23% vs 2024 (€ 100,903) Unchanged	▼ 23%
Bank debt	€ 51,935 Bank debt 2022: € 51,935 First fiscal year in the series	€ 41,332 Bank debt 2023: € 41,332 ▼ 20% vs 2022 (€ 51,935) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 41,332) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 603,042 Balance sheet total 2022: € 603,042 First fiscal year in the series	€ 497,190 Balance sheet total 2023: € 497,190 ▼ 18% vs 2022 (€ 603,042) Unchanged	€ 533,432 Balance sheet total 2024: € 533,432 ▲ 7% vs 2023 (€ 497,190) Unchanged	€ 405,689 Balance sheet total 2025: € 405,689 ▼ 24% vs 2024 (€ 533,432) Unchanged	▼ 24%
Employees (FTE)	0.3 Employees (FTE) 2022: 0.3 First fiscal year in the series	0.2 Employees (FTE) 2023: 0.2 ▼ 0.1 vs 2022 (0.3) Unchanged	0.1 Employees (FTE) 2024: 0.1 ▼ 0.1 vs 2023 (0.2) Unchanged	-

Key figures of APOTHEEK VERSCHAEVE-BARTELEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2026 has not been filed yet; it was expected before 31 October 2026.

What happened to APOTHEEK VERSCHAEVE-BARTELEN?

What happened at APOTHEEK VERSCHAEVE-BARTELEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 3, 2025 New annual accounts for financial year 2025: profit of € 77,830 (▼ 3% vs 2024). Source: NBB ↗
2015 Pamixx became a director. NBB
Apr 29, 1994 New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
Jan 31, 1994 Start of the company according to the CBE. KBO

In short

From € 77,607 profit in 2022 to € 77,830 profit in 2025.

Paid € 1,494 in corporate taxes since 2022.

Best year ever: 2023, with € 80,612 profit.

Paid out € 496,733 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Waelput Invest 100%

The stake of Waelput Invest comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VERSCHAEVE-BARTELEN

Behind APOTHEEK VERSCHAEVE-BARTELEN is Pamixx. The shares are held by Waelput Invest (100%).

Directors

According to the 2025 annual accounts

Pamixx

Director · represented by Mia Bartelen

since 2015

Shareholders

Waelput Invest

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpstraat 141

2070 Beveren-Kruibeke-Zwijndrecht

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0451.903.303

VAT number

BE 0451.903.303

Registered office

Dorpstraat 141, 2070 Beveren-Kruibeke-Zwijndrecht

Names & denominations

APOTHEEK VERSCHAEVE-BARTELEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 January 1994

Peppol

Active · Active since 5 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VERSCHAEVE-BARTELEN

Warning lights

Financials

What happened to APOTHEEK VERSCHAEVE-BARTELEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions